The European Research Council (ERC) has announced the results of its latest Consolidator Grant competition, selecting 349 mid-career researchers for a combined €728 million in funding.
New vaccine data from Israel suggests that the double-dose of Pfizer is performing at the expected rate of 95% efficiency - with the possibility that it is performing even better than that being further investigated.
An initial £2.5 million will launch the 'G2P-UK' National Virology Consortium, which will investigate COVID-19 mutations to figure out how they impact vaccines.
The projects will happen in 14 Member States and the United Kingdom, with 36 million in funding to get COVID-19 plasma to patients - boosting their immune response to the virus.
The team at Rush University Medical Center have conducted the first US investigation into opioid use and pancreatic cancer - how could this change prescriptions?
While cities only occupy around 3% of the Earth, they are where 50% of the world's population live - but they are not usually included in global climate calculations, meaning that urban environmental problems can slip under the radar.
Jane C Khoury & Shelley R Ehrlich from Division of Biostatistics and Epidemiology, Cincinnati Children’s Hospital Medical Center, highlight the consequences of foetal development in a “sweet” uterus – including the short- and long-term transgenerational outcomes.
Here, we discover that SymlConnect digitises the paper-processes, offering remote monitoring to improve efficiency in care monitoring and reducing the waiting list exacerbated by the COVID-19 pandemic.
Frank F Vincenzi, Professor Emeritus, University of Washington, tells us about the mammalian dive response (MDR), drawing on the case of the woman who developed a fatal heart rhythm while SCUBA diving.
In 2018 the UK proposed stronger 'online harms' regulation, to address harmful content that children can see on social media - by asking tech giants to do better self-regulation or face Government investigation.
While diabetes has been declared as a signifier for infection complications, researchers now say that data suggests it is three times as likely these individuals have severe COVID or are hospitalised.
According to the American Heart Association, women face a stronger heart attack risk than men - they are 20% more likely to develop heart failure, and to die.
Teva and Cephalon faced the €60.5 million antitrust fine, after both companies were found to be actively suppressing the existence of cheaper medicine.
